Mortality benefits of thromboprophylaxis – Authors' reply

Nicholas D. Klemen; Paul L. Feingold; Barry Hashimoto; Cary P. Gross; Kevin Y. Pei

doi:10.1016/S2352-3026(20)30322-7

Mortality benefits of thromboprophylaxis – Authors' reply

Nicholas D. Klemen
, Paul L. Feingold
, Barry Hashimoto
, Cary P. Gross
, Kevin Y. Pei

New York University Abu Dhabi

Memorial Sloan-Kettering Cancer Center
Harvard University
Yale University
Indiana University Bloomington

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	e783-e784
Journal	The Lancet Haematology
Volume	7
Issue number	11
DOIs	https://doi.org/10.1016/S2352-3026(20)30322-7
State	Published - Nov 2020

Access to Document

10.1016/S2352-3026(20)30322-7

Cite this

@article{94a138e9fab742898fb9620ac6fbd5bc,

title = "Mortality benefits of thromboprophylaxis – Authors' reply",

author = "Klemen, \{Nicholas D.\} and Feingold, \{Paul L.\} and Barry Hashimoto and Gross, \{Cary P.\} and Pei, \{Kevin Y.\}",

year = "2020",

month = nov,

doi = "10.1016/S2352-3026(20)30322-7",

language = "English",

volume = "7",

pages = "e783--e784",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Elsevier Ltd.",

number = "11",

}

TY - JOUR

T1 - Mortality benefits of thromboprophylaxis – Authors' reply

AU - Klemen, Nicholas D.

AU - Feingold, Paul L.

AU - Hashimoto, Barry

AU - Gross, Cary P.

AU - Pei, Kevin Y.

PY - 2020/11

Y1 - 2020/11

UR - https://www.scopus.com/pages/publications/85092905546

U2 - 10.1016/S2352-3026(20)30322-7

DO - 10.1016/S2352-3026(20)30322-7

M3 - Letter

C2 - 33091348

AN - SCOPUS:85092905546

SN - 2352-3026

VL - 7

SP - e783-e784

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 11

ER -

Mortality benefits of thromboprophylaxis – Authors' reply

Access to Document

Other files and links

Cite this